LEVIGRESS SYRUP

About

Levigress Syrup, containing the active compound levetiracetam, is a modern anticonvulsant medication extensively used in the comprehensive management of a diverse range of seizure disorders. Its precise mechanism of action, while not fully elucidated, is understood to involve a unique interaction with the synaptic vesicle protein 2A (SV2A) in the brain. By binding to SV2A, levetiracetam is believed to modulate the release of neurotransmitters, thereby helping to normalize excessive neuronal excitability without directly affecting ion channels or GABAergic transmission in the same way as older anticonvulsants. This distinct mechanism contributes to its broad-spectrum efficacy. Levetiracetam is highly effective as both monotherapy and adjunctive therapy for partial-onset seizures, myoclonic seizures characteristic of juvenile myoclonic epilepsy, and primary generalized tonic-clonic seizures. Its favorable pharmacokinetic profile, including minimal hepatic metabolism and few drug-drug interactions, makes it a valuable and generally well-tolerated option in epilepsy treatment.

Uses

• Treatment of partial-onset seizures.
• Management of myoclonic seizures in juvenile myoclonic epilepsy.
• Therapy for primary generalized tonic-clonic seizures.
• Adjunctive therapy for various seizure types.

Directions For Use

Administer orally, usually twice daily, with or without food, as directed by a physician. Measure the dose accurately using the provided measuring device.

Benefits

• Broad-spectrum efficacy against various seizure types.
• Generally well-tolerated with a favorable safety profile.
• Minimal drug-drug interactions compared to other anticonvulsants.
• Available in a liquid form for easier administration, especially for children.
• Does not require routine therapeutic drug monitoring.
• Effective as both monotherapy and adjunctive therapy.

Side Effects

• Somnolence
• Asthenia (weakness)
• Dizziness
• Headache
• Irritability
• Nervousness
• Anorexia
• Nausea
• Diarrhea
• Behavioral changes
• Aggression
• Fatigue

Safety Measures

• Alcohol - Concurrent use of alcohol with levetiracetam can increase central nervous system depression, leading to enhanced drowsiness and dizziness. It is advisable to avoid or limit alcohol intake.
• Pregnancy - Levetiracetam is generally considered one of the safer antiepileptic drugs during pregnancy, but it does cross the placenta. Use only if clearly needed, and discuss risks and benefits with a healthcare provider.
• Breastfeeding - Levetiracetam is excreted into breast milk. While generally considered compatible with breastfeeding, monitor the infant for sedation or irritability. Consult a physician before breastfeeding.
• Liver - Levetiracetam is minimally metabolized by the liver. Dose adjustments are generally not required for patients with liver impairment.
• Kidney - Levetiracetam is primarily eliminated via renal excretion. Dosage adjustments are necessary in patients with impaired renal function to prevent accumulation and potential adverse effects.
• Lung - No specific direct adverse effects on lung function are commonly associated with levetiracetam.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.